Complete Copier Cure is categorized under Copying and Duplicating Services in Sherman Oaks, CA and active since 2003.
Complete Copier Cure was established in 2003, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Copying and Duplicating Services business, which does work in the B2B market, and is classified as a Copying and Duplicating Services, under code number 323111 by the NAICS.
If you are seeking more information, feel free to contact Ben Toubian at the company’s single location by writing to 15122 Ventura Boulevard, Sherman Oaks, California CA 91403 or by phoning (617) 389-9706. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Complete Copier Cure |
| Contact Person: | Ben Toubian |
| Address: | 15122 Ventura Boulevard, Sherman Oaks, California 91403 |
| Phone Number: | (617) 389-9706 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Copying and Duplicating Services |
| SIC Code: | 7334 |
| NAICS Code: | 323111 |
| Share This Business: |
Complete Copier Cure was started in 2003 to provide professional Copying and Duplicating Services under the SIC code 7334 and NAICS code 323111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Ben Toubian for inquiries that concern Complete Copier Cure by calling the company number (617) 389-9706, as your correspondence is most welcome. Additionally, the physical location of the single location of Complete Copier Cure can be found at the coordinates as well as the street address 15122 Ventura Boulevard in Sherman Oaks, California 91403.
For its online presence, you may visit Complete Copier Cure’s website at and engage with its social media outlets through on Twitter and on Facebook.